FEBS Letters
Retraction Statement: miR‐188 promotes senescence of lineage‐negative bone marrow cells by targeting MAP3K3 expression
FEBS Letters, Volume 596, Issue 16, Page 2086-2086, August 2022.
FEBS Letters
Genetic, metabolic and immunological features of cancers with NRF2 addiction
FEBS Letters, Volume 596, Issue 16, Page 1981-1993, August 2022.
FEBS Letters
Middle East respiratory syndrome coronavirus ORF4b protein inhibits TLR7‐ and TLR9‐dependent alpha interferon induction
FEBS Letters, Volume 596, Issue 19, Page 2538-2554, October 2022.
FEBS Letters
Maintenance of small molecule redox homeostasis in mitochondria
FEBS Letters, Volume 597, Issue 2, Page 205-223, January 2023.
FEBS Letters
E. coli cytochrome bd‐I requires Asp58 in the CydB subunit for catalytic activity
FEBS Letters, Volume 596, Issue 18, Page 2418-2424, September 2022.
FEBS Letters
A simplified and easy‐to‐use HIP HOP assay provides insights into chalcone antifungal mechanisms of action
FEBS Letters, Volume 596, Issue 23, Page 3087-3102, December 2022.
FEBS Letters
An excess of glycolytic enzymes under glucose‐limited conditions may enable Saccharomyces cerevisiae to adapt to nutrient availability
FEBS Letters, Volume 596, Issue 24, Page 3203-3210, December 2022.
FEBS Letters
The fusion of quantitative molecular proteomics and immune‐oncology: a step towards precision medicine in cancer therapeutics
FEBS Letters, Volume 596, Issue 21, Page 2721-2735, November 2022.
FEBS Letters
Novel insights into the regulation of cellular catabolic metabolism in macrophages through nuclear receptors
FEBS Letters, Volume 596, Issue 20, Page 2617-2629, October 2022.
FEBS Letters
Structural characterisation of a MAPR‐related archaeal cytochrome b5M protein
FEBS Letters, Volume 596, Issue 18, Page 2409-2417, September 2022.